Recent advances in photonic dosimeters for medical radiation therapy
- 44 Downloads
Radiation therapy, which uses X-rays to destroy or injure cancer cells, has become one of the most important modalities to treat the primary cancer or advanced cancer. High resolution, water equivalent and passive X-ray dosimeters are highly desirable for developing quality assurance (QA) systems for novel cancer therapy like microbeam radiation therapy (MRT) which is currently under development. Here we present the latest developments of high spatial resolution scintillator based photonic dosimeters, and their applications to clinical external radiation beam therapies: specifically high energy linear accelerator (LINAC) photon beams and low energy synchrotron photon beams. We have developed optical fiber dosimeters with spatial resolutions ranging from 50 to 500 mm and tested them with LINAC beams and synchrotron microbeams. For LINAC beams, the fiberoptic probes were exposed to a 6 MV, 10 cm by 10 cm Xray field and, the beam profiles as well as the depth dose profiles were measured at a source-to-surface distance (SSD) of 100 cm. We have also demonstrated the possibility for temporally separating Cherenkov light from the pulsed LINAC scintillation signals. Using the 50 mm fiber probes, we have successfully resolved the microstructures of the microbeams generated by the imaging and medical beamline (IMBL) at the Australian Synchrotron and measured the peak-to-valley dose ratios (PVDRs). In this paper, we summarize the results we have achieved so far, and discuss the possible solutions to the issues and challenges we have faced, also highlight the future work to further enhance the performances of the photonic dosimeters.
Keywordsfiber-optic dosimetry scintillators X-ray Cherenkov radiation cancer therapy microbeam radiation therapy (MRT)
Unable to display preview. Download preview PDF.
This project was supported by UOW’s Global Challenges Program. This research was undertaken on the Imaging and Medical beamline at the Australian Synchrotron, Victoria, Australia (AS162/ IMBL/10829). This research has been conducted with the support of the Australian Government Research Training Program Scholarship.
- 5.Rusby D R, Brenner C M, Armstrong C, Wilson L A, Clarke R, Alejo A, Ahmed H, Butler N M H, Haddock D, Higginson A, McClymont A, Mirfayzi S R, Murphy C, Notley M, Oliver P, Allott R, Hernandez-Gomez C, Kar S, McKenna P, Neely D. Pulsed X-ray imaging of high-density objects using a ten picosecond highintensity laser driver. In: Proceedings of Emerging Imaging & Sensing Technologies. 2016, 9992: 99920ECrossRefGoogle Scholar
- 6.Deas R M, Wilson L A, Rusby D, Alejo A, Allott R, Black P P, Black S E, Borghesi M, Brenner C M, Bryant J, Clarke R J, Collier J C, Edwards B, Foster P, Greenhalgh J, Hernandez-Gomez C, Kar S, Lockley D, Moss R M, Najmudin Z, Pattathil R, Symes D, Whittle M D, Wood J C, McKenna P, Neely D. A laser driven pulsed X-ray backscatter technique for enhanced penetrative imaging. Journal of X-Ray Science and Technology, 2015, 23(6): 791–797CrossRefGoogle Scholar
- 19.Bouchet A, Lemasson B, Christen T, Potez M, Rome C, Coquery N, Le Clec'h C, Moisan A, Brauer-Krisch E, Leduc G, Remy C, Laissue J A, Barbier E L, Brun E, Serduc R. Synchrotron microbeam radiation therapy induces hypoxia in intracerebral gliosarcoma but not in the normal brain. Radiotherapy and Oncology, 2013, 108(1): 143–148CrossRefGoogle Scholar
- 20.Crosbie J C, Anderson R L, Rothkamm K, Restall C M, Cann L, Ruwanpura S, Meachem S, Yagi N, Svalbe I, Lewis R A, Williams B R, Rogers P A. Tumor cell response to synchrotron microbeam radiation therapy differs markedly from cells in normal tissues. International Journal of Radiation Oncology, Biology, Physics, 2010, 77(3): 886–894CrossRefGoogle Scholar
- 21.Regnard P, Le Duc G, Brauer-Krisch E, Clair C, Kusak A, Dallery D, et al.. Microbeam radiation therapy (MRT) applied to rats ́brain tumor: finding the best compromise between normal tissue sparing and tumor curing. European Journal of Cancer Supplements, 2005, 3 (2): 396Google Scholar
- 22.Serduc R, Vérant P, Vial J C, Farion R, Rocas L, Rémy C, Fadlallah T, Brauer E, Bravin A, Laissue J, Blattmann H, van der Sanden B. In vivo two-photon microscopy study of short-term effects of microbeam irradiation on normal mouse brain microvasculature. International Journal of Radiation Oncology, Biology, Physics, 2006, 64(5): 1519–1527CrossRefGoogle Scholar
- 24.Cornelius I, Guatelli S, Fournier P, Crosbie J C, Sanchez Del Rio M, Bräuer-Krisch E, Rosenfeld A, Lerch M. Benchmarking and validation of a Geant4-SHADOW Monte Carlo simulation for dose calculations in microbeam radiation therapy. Journal of Synchrotron Radiation, 2014, 21(3): 518–528CrossRefGoogle Scholar
- 26.Fournier P, Cornelius I, Dipuglia A, Cameron M, Davis J A, Cullen A, Petasecca M, Rosenfeld A B, Brauer-Krisch E, Häusermann D, Stevenson A W, Perevertaylo V, Lerch M L F. X-Tream dosimetry of highly brilliant X-ray microbeams in the MRT hutch of the Australian Synchrotron. Radiation Measurements, 2017 doi: 10.1016/j.radmeas.2017.01.011Google Scholar